| Product Name | MF | CAS | Details |
|---|
| 4-Fluorothiophene-2-carbonitrile | C5H2FNS | 32431-77-9 | Details |
| Erlotinib Related compound A | C25H30ClN3O5 | 299912-59-7 | Details |
| 8-Chloroquinazoline | C8H5ClN2 | 7557-04-2 | Details |
| 4-(Phenanthren-9-Yl)-N-phenylaniline | C26H19N | 936916-08-4 | Details |
| 2,3,4,6-Tetra-O-acetyl-β-D-mannopyranosyl azide | C14H19N3O9 | 65864-60-0 | Details |
| Sucrose hexasulfate (potassium) | C12H23KO29S6 | 386229-70-5 | Details |
| Olopatadine Impurity 13 | C17H22NOP | 962-95-8 | Details |
| tert-Butyl 3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)azetidine-1-carboxylate | C14H26BNO4 | 2304635-53-6 | Details |
| Mizolastine Impurity 9 | C25H27FN6O | 935860-12-1 | Details |
| Metaraminol Impurity 54 | C16H19NO2 | 47017-04-9 | Details |
| Ketoprofen Impurity 38 | C12H13NO2 | 24131-07-5 | Details |
| Irinotecan Impurity 52 | C11H20N2O2 | 1026078-50-1 | Details |
| (R)-4-Amino-5-phenylpentanoic acid | C11H15NO2 | 63328-06-3 | Details |
| (E)-Pent-3-en-1-ol | C5H10O | 764-37-4 | Details |
| Brivaracetam Impurity Z | C8H14O2 | 22530-99-0 | Details |
| Upadacitinib Impurity 24 | C5H6F6N2O | 406-11-1 | Details |
| Carbidopa Ep Impurity C | C11H16N2O4 | 84488-77-7 | Details |
| Isoproterenol Impurity 15 | C11H17NO2 | 3506-32-9 | Details |
| 7-Nitro-3,4-dihydro-2H-benzo[b][1,4]dioxepine | C9H9NO4 | 78288-94-5 | Details |
| D-Xylo-[2]Hexulosonic Acid Methyl Ester | C7H12O7 | 67776-07-2 | Details |
| 6-Methoxy-1H-indol-4-amine | C9H10N2O | 282547-67-5 | Details |
| Dyclonine | C9H20ClN | 80840-88-6 | Details |
| 4-((Trifluoromethyl)sulfonyl)benzonitrile | C8H4F3NO2S | 312-21-0 | Details |
| Ethyl 2-chloro-6-methylnicotinate | C9H10ClNO2 | 39073-14-8 | Details |
| 5,6,7,8-Tetrahydro-imidazo[1,2-a]pyrazine DiHCl | C6H10ClN3 | 735266-95-2 | Details |
| 1-Methylpyrrolidine-2,3-dione | C5H7NO2 | 42599-26-8 | Details |
| Empagliflozin Impurity 268 | C7H3Br2ClO2 | 501009-13-8 | Details |
| Polaprezinc Impurity 2 | C17H16N4O5 | 7389-97-1 | Details |
| Thiamine Impurity 23 | C24H30N8O2S2 | 105070-51-7 | Details |
| 3-Ethyl-1-methyl-1H-imidazol-3-ium (S)-2-hydroxypropanoate | C9H16N2O3 | 878132-19-5 | Details |
| Clotrimazole Impurity 7 | C21H20O | 968-39-8 | Details |
| 1-Deoxy-1-L-proline-D-fructose | C11H19NO7 | 29118-61-4 | Details |
| 2-[(2,6-Dichlorophenyl)amino]-α-oxobenzeneacetic acid | C14H9Cl2NO3 | 66156-75-0 | Details |
| (1R,2R)-2-(1-Pyrrolidinyl)cyclohexanamine | C10H20N2 | 885677-92-9 | Details |
| Dimethyl thiazolidine-2,4-dicarboxylate | C7H11NO4S | 318233-97-5 | Details |
| Pemetrexed Impurity 41 | C11H14O3S | 778-29-0 | Details |
| Brivaracetam Impurity 4 | C8H17N3O2 | 2432911-41-4 | Details |
| Mono(2-ethyl-5-hydroxyhexyl) phthalate | C16H22O5 | 40321-99-1 | Details |
| 4-Bromo-6-methoxyquinoline-3-carboxylic acid | C11H8BrNO3 | 872714-51-7 | Details |
| 3,5-Diaminobenzohydrazide | C7H10N4O | 98335-17-2 | Details |
| Oseltamivir Impurity 90 | C19H32N2O4 | 312904-18-0 | Details |
| Upadacitinib Impurity 50 | C16H20ClNO3 | 2460133-49-5 | Details |
| N-Octylacrylamide | C11H21NO | 10124-68-2 | Details |
| N,2-Diethyl-2-isopropyl-3-methylbutanamide | C12H25NO | 51115-70-9 | Details |
| 4-Benzofurancarbaldehyde | C9H6O2 | 95333-13-4 | Details |
| (4S)-4-(4-Cyano-2-methoxyphenyl)-5-(cyclopentyloxy)-1,4-dihydro-2,8-dimethyl-1,6-naphthyridine-3-carboxamide (Finerenone Impurity) | C24H26N4O3 | 2389019-54-7 | Details |
| 3-Ethoxyisonicotinonitrile | C8H8N2O | 78790-86-0 | Details |
| Lipoic Acid Impurity 17 | C9H16O2S2 | 46236-19-5 | Details |
| 1-(Methoxymethyl)cyclopropane-1-carboxylic acid | C6H10O3 | 67567-55-9 | Details |
| Decitabine Impurity 3 | C7H14N4O4 | 69304-65-0 | Details |
| N-Benzyloxetan-3-amine | C10H13NO | 1015937-48-0 | Details |
| (αS)-α-Methylbenzenemethanesulfonic acid | C8H10O3S | 86963-38-4 | Details |
| Meropenem Impurity 4 | C17H18N2O7 | 104873-15-6 | Details |
| Carboxy Terbinafine | C21H23NO2 | 99473-14-0 | Details |
| (2R,3S)-2-tert-Butoxycarbonylamino-3-phenyl butyric acid | C15H21NO4 | 321524-48-5 | Details |
| Progesterone Impurity 33 | C23H34O4 | 88128-61-4 | Details |
| Betamethasone Impurity 112 | C24H30ClFO5 | 25122-45-6 | Details |
| (2-Isopropylphenyl)hydrazine hydrochloride | C9H15ClN2 | 58928-82-8 | Details |
| tert-butyl 4-(4-amino-3-(trifluoromethyl)benzyl)piperazine-1-carboxylate | C17H24F3N3O2 | 859027-30-8 | Details |
| Imidafenacin Impurity 6 | C18H18N2O4 | 503598-07-0 | Details |
| Verapamil Ep Impurity H | C26H36N2O4 | 67018-83-1 | Details |
| 6-(Trifluoromethoxy)-1H-indole-2-carboxylic acid | C10H6F3NO3 | 923259-70-5 | Details |
| 2-Chloro-4,6-dimethyl-1,3,5-triazine | C5H6ClN3 | 30894-84-9 | Details |
| 2-Thiomorpholinoethanamine | C6H14N2S | 53515-36-9 | Details |
| Ethyl 2-(2-chlorophenyl)-2-oxoacetate | C10H9ClO3 | 62123-75-5 | Details |
| 4-(Piperidin-4-ylmethyl)aniline | C12H18N2 | 37581-35-4 | Details |
| Nimodipine Impurity 11 | C18H20N2O7 | 85677-95-8 | Details |
| 4-Bromo-N-((tetrahydrofuran-2-yl)methyl)benzamide | C12H14BrNO2 | 326898-76-4 | Details |
| Rosuvastatin Impurity 122 | C10H19ClO4 | 404958-68-5 | Details |
| Nebramine; Tobramycin Ep Impurity B | C12H26N4O5 | 34051-04-2 | Details |
| 2H-1-Benzopyran-2-methanol, α,α'-[iminobis(methylene)]bis[6-fluoro-3,4-dihydro-, hydrochloride (1:1), (αR,α'R,2S,2'S)- | 920275-19-0 | Details |
| 9-Oxo-9H-thioxanthene-2-carboxylic acid | C14H8O3S | 25095-94-7 | Details |
| Calcium Dobesilate Impurity 4 | C6H6O8S2 | 4444-23-9 | Details |
| Methyl 1-methyl-2-nitro-1H-imidazole-5-carboxylate | C6H7N3O4 | 40361-79-3 | Details |
| Salmeterol Ep Impurity G; Salmeterol-N-Alkyl Impurity (Usp) | C50H72N2O7 | 2470130-36-8 | Details |
| Betamethasone Impurity 68 | C22H28O4 | 37413-99-3 | Details |
| Imrecoxib Impurity 5 | C21H23NO3S | 2305368-53-8 | Details |
| 1-(4-Chlorophenyl)-2-hydroxyethanone | C8H7ClO2 | 27993-56-2 | Details |
| 2-(3,4-Dichlorophenyl)acetamide | C8H7Cl2NO | 868697-78-3 | Details |
| Isosorbide Impurity 14 | C8H11NO7 | 39813-48-4 | Details |
| Nintedanib Impurity 76 | C9H8Cl2N2O3 | 78466-25-8 | Details |
| 2,6-Diethylnaphthalene | C14H16 | 59919-41-4 | Details |
| 1-(2,4-Dimethoxyphenyl)-N-methylmethanamine hydrochloride | C10H16ClNO2 | 326473-23-8 | Details |
| 2-(Pyrrolidin-1-ylmethyl)piperidine | C10H20N2 | 100158-63-2 | Details |
| 4h,5h,6h,7h,8h-Cyclohepta[d][1,2]oxazole-3-carboxylic acid | C9H11NO3 | 33230-32-9 | Details |
| Dydrogesterone Impurity 24 | C25H36O4 | 32164-74-2 | Details |
| Methotrexate Impurity 38 | C22H26N8O5 | 65148-64-3 | Details |
| (4R)-4-(4-Cyano-2-methoxyphenyl)-5-(cyclobutyloxy)-1,4-dihydro-2,8-dimethyl-1,6-naphthyridine-3-carboxamide (Finerenone Impurity) | C23H24N4O3 | 2389019-53-6 | Details |
| 4-(4-Amino-6,7-dimethoxyquinazolin-2-yl)piperazine-1-carbaldehyde hydrochloride | C19H25N5O4 | 84050-21-5 | Details |
| ((3aR,6R,7S,7aS)-6,7-Dihydroxy-2,2-dimethyltetrahydro-4H-[1,3]dioxolo[4,5-c]pyran-6-yl)methyl sulfamate | C9H17NO8S | 851957-35-2 | Details |
| Piracetam Impurity 17 | C8H12N2O | 7060-52-8 | Details |
| 5-(Trifluoromethyl)furan-2-carboxylic acid | C6H3F3O3 | 56286-73-8 | Details |
| 1-[(3aS,8aS)-Tetrahydro-2,2-dimethyl-4,4,8,8-tetraphenyl-1,3-dioxolo[4,5-e][1,3,2]dioxaphosphepin-6-yl]pyrrolidine | C35H36NO4P | 582298-51-9 | Details |
| (1R)-1-Cyclopropylethanamine | C5H11N | 6240-96-6 | Details |
| Indobufen Impurity 14 | C12H15NO4 | 6973-78-0 | Details |
| 6-Bromo-4,8-dichloroquinoline-3-carbonitrile | C10H3BrCl2N2 | 886362-77-2 | Details |
| Procaterol Impurity 9 | C16H22N2O3 | 94198-40-0 | Details |
| 2,3-Dihydro-1h-indene-2-carbaldehyde | C10H10O | 37414-44-1 | Details |
| Baclofen Impurity 8 | C11H11ClO4 | 103857-58-5 | Details |
| Product Total： Product Page： | ||||
| 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 | ||||